News 2018-10-06
Porton will attend 2018 CPhI WW
We own and operate 4 Process Technology Centers and 2 Manufacturing Sites [including one US FDA, Japan PDMA-approved facilities] across China. Supported by >1,500 customer first-oriented employees [including >500 Process Scientists, Operations, Quality Assurance, EHS and Program Management professionals]. Our sites are operated to global quality and environmental standards under a centralized management system.

Others
More
News 2026-03-22
Porton and Jianxiang Forge Strategic Partnership to Build a New High Ground for Large-scale Peptide Drug Manufacturing
Porton and Jianxiang partner to deliver integrated peptide CDMO services from development to commercial manufacturing, offering scalable, compliant solutions for global clients.

News 2026-03-03
Porton Wins “2025 Best CRO” Award from Daewoong Pharma
Daewoong Pharma highly recognized Porton’s contributions to its drug development through active cooperation based on Porton’s excellent capabilities and expertise.